14.07.2016 • NewsElaine BurridgeAMRIEuticals

AMRI Boosts API Business with Euticals Buy

(c) AJP/Shutterstock
(c) AJP/Shutterstock

US-based contract research and manufacturing organization AMRI has completed the acquisition of Prime European Therapeuticals, also known as Euticals, for €315 million. A privately held company headquartered in Lodi, Italy, Euticals specializes in custom synthesis and API manufacture and operates a network of facilities, primarily in France, Italy, Germany, and the US.

Euticals has expertise in technologies and products that are niche or have a high barrier to entry, including certain tetracyclines, monobactams, sterile and fermented APIs, and controlled substances.

William Martin, AMRI’s president and CEO, said the acquisition expands its customer base, further diversifies its revenue streams and moves the company significantly closer to its goal of reaching $1 billion in annual revenues by 2018.

The transaction was funded by a combination of shares of AMRI common stock, a seller note, and cash. The deal was initially announced on May 5, 2016. Euticals is the second API firm that AMRI has bought in the past year. In July 2015, it paid $174 million for Spain’s Gadea Pharmaceutical, a company specializing in technically complex APIs and finished drug products.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.